Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Innovate (VATE) over the last 16 years, with Q3 2025 value amounting to $200000.0.

  • Innovate's Capital Expenditures fell 3333.33% to $200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.2 million, marking a year-over-year increase of 30000.0%. This contributed to the annual value of $19.0 million for FY2024, which is 326.09% up from last year.
  • Latest data reveals that Innovate reported Capital Expenditures of $200000.0 as of Q3 2025, which was down 3333.33% from -$4.4 million recorded in Q2 2025.
  • Innovate's Capital Expenditures' 5-year high stood at $18.7 million during Q4 2024, with a 5-year trough of -$5.6 million in Q2 2024.
  • Over the past 5 years, Innovate's median Capital Expenditures value was $4.5 million (recorded in 2023), while the average stood at $4.4 million.
  • Examining YoY changes over the last 5 years, Innovate's Capital Expenditures showed a top increase of 31555.56% in 2024 and a maximum decrease of 22444.44% in 2024.
  • Quarter analysis of 5 years shows Innovate's Capital Expenditures stood at $9.1 million in 2021, then crashed by 51.65% to $4.4 million in 2022, then rose by 2.27% to $4.5 million in 2023, then skyrocketed by 315.56% to $18.7 million in 2024, then tumbled by 98.93% to $200000.0 in 2025.
  • Its Capital Expenditures was $200000.0 in Q3 2025, compared to -$4.4 million in Q2 2025 and $4.7 million in Q1 2025.